Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,157 | 161 | 80 | 13 | -3,011 |
| Depreciation Amortization | 902 | 708 | 475 | 234 | 909 |
| Accounts receivable | 19 | -726 | -1,007 | -859 | -349 |
| Accounts payable and accrued liabilities | 312 | 678 | 749 | 593 | 151 |
| Other Working Capital | -2,206 | -1,046 | 46 | 393 | 1,779 |
| Other Operating Activity | -331 | 48 | 258 | 266 | 213 |
| Operating Cash Flow | $-147 | $-177 | $601 | $640 | $-308 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -397 | -312 | -237 | -76 | -255 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -150 |
| Investing Cash Flow | $-397 | $-312 | $-237 | $-76 | $-405 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $5 | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1,059 | 1,059 | 1,059 | 1,059 | 1,772 |
| End Cash Position | 520 | 570 | 1,423 | 1,623 | 1,059 |
| Net Cash Flow | $-539 | $-489 | $364 | $564 | $-713 |
| Free Cash Flow | |||||
| Operating Cash Flow | -147 | -177 | 601 | 640 | -308 |
| Capital Expenditure | -398 | -312 | -237 | -76 | -266 |
| Free Cash Flow | -545 | -489 | 364 | 564 | -574 |